Originally aired in 2023, Molly Jacobson interviews Dr. Kim Agnew about the groundbreaking trials of Monepantel, a sheep dewormer repurposed as a potential treatment for canine lymphoma. Discover the science behind this innovative therapy, its potential to stabilize lymphoma, and how it compares to traditional treatments like chemotherapy and prednisone. 

Key Topics: 

Your Voice Matters!  

If you have a question for our team, or if you want to share your own hopeful dog cancer story, we want to hear from you! Go to https://www.dogcancer.com/ask to submit your question or story, or call our Listener Line at +1 808-868-3200 to leave a question.  

Related Videos: 

https://www.youtube.com/watch?v=_92w6TTXM5c  

https://www.youtube.com/watch?v=uAZrPM1X8ww  

Related Links: 

PharmAust Dog Lymphoma Clinical Trial: https://www.pharmaust.com/petdogtrial/ 

Chapters: 

00:00 Introduction 

00:30 Meet Dr. Kim Agnew and Monepantel Overview 

01:15 The Origin of Monepantel: From Dewormer to Cancer Fighter 

03:30 How Monepantel Targets Cancer Cells 

07:00 Insights on Clinical Trials for Canine Lymphoma 

09:30 Benefits of Monepantel: A Daily Pill for Dogs 

12:00 Comparing Monepantel to Chemotherapy and Prednisone 

14:45 Early Trial Results: Stabilizing Lymphoma in Dogs 

18:30 Why Lymphoma Was Chosen for Trials 

20:00 Potential for Treating Other Cancers in Dogs 

23:15 How to Enroll Dogs in Clinical Trials 

26:45 Side Effects and Safety of Monepantel 

31:00 Future Trials and Research Goals 

34:30 Closing Thoughts and Resources 

33:55 Closing Remarks and Resources 

Get to know Kim Agnew, BVSc:

https://www.dogcancer.com/people/kim-agnew-bvsc/    

For more details, articles, podcast episodes, and quality education, go to the episode page: https://www.dogcancer.com/podcast/  

Learn more about your ad choices. Visit megaphone.fm/adchoices